The REPROCELL Blog

Simon Padbury

Simon Padbury
Strategy and Marketing Planner, REPROCELL

Recent Posts

REPROCELL’s Prof Stefan Przyborski to chair the SMi 2nd Annual Conference on 3D Cell Culture – London UK, 21-22 February 2018

[fa icon="calendar'] Jan 24, 2018 5:08:00 PM / by Simon Padbury posted in 3D Cell Culture, Bio-engineered Tissue Models

[fa icon="comment"] 0 Comments

The SMi Group’s conference on 3D Cell Culture will be held on 21-22 February 2018. The venue is the Copthorne Tara Hotel in Kensington, London, UK.

 Find out more at www.3d-CellCulture.com

REPROCELL Europe’s CSO Professor Stefan Przyborski will chair the first day of the conference.

From the Conference Overview:

Building on the sell-out success of the launch event, SMi Group is delighted to announce the return of 3D Cell Culture, taking place on 21st and 22nd of February 2018, in London UK.
Whilst still in its infancy, 3D Cell Culture is rapidly growing with not only a widespread reach that can be seen across a number of different fields such as 3D bioprinting and microfluidics, but also with incredible potential for industrial application. The 2nd annual conference will explore these overlapping areas and will also update delegates on pioneering developments in surrounding topics such as disease models, organoids, organ-on-a-chip technologies and iPSC advances.
Continue reading [fa icon="long-arrow-right"]

Formation of human tissue to improve drug testing and reduce animal research

[fa icon="calendar'] Jan 19, 2018 3:30:56 PM / by Simon Padbury posted in Drug Discovery, Human Tissues, 3D Cell Culture, Bio-engineered Tissue Models

[fa icon="comment"] 0 Comments

REPROCELL’s Alvetex, a scaffold for 3D cell culture and bioengineered tissue models, is in the Durham University (UK) News yesterday, at https://www.dur.ac.uk/news/newsitem/?itemno=33385

Developed at the university by Professor Stefan Prsyborski, Alvetex was first commercialised by the spin-out company Reinnervate – based at NETPark in County Durham, UK. Reinnervate was acquired by REPROCELL Inc. (Japan) in 2014.

Stefan Przyborski is Professor of Cell Technology at Durham University’s Department of Biosciences and Chief Scientific Officer of REPROCELL Europe Ltd.

Continue reading [fa icon="long-arrow-right"]